Ellis Levine MD

PubMed

• 1 citations
  Real-World Plasma Thymidine Kinase Activity in High-Risk and Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Trea...
  Thomas N O'Connor, Emily Schultz, Sheheryar Kabraji, Ellis Levine, Amy J Williams
  JCO Precision Oncology. 2026-01-01
• Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT.
  Karin Ribi, Bernard F Cole, Gini F Fleming, Barbara A Walley, Prudence A Francis
  Cancer. 2025-10-01
• Area deprivation index and breast cancer outcomes among patients in Western New York.
  Malak Alharbi, Jayasree Krishnan, Arya Mariam Roy, Archit Patel, Ankita Kapoor
  Breast Cancer Research and Treatment. 2025-08-01

Journal Articles

• Kidney cancer, version 22014  
  Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolgr GB, Chang SS, Choueriri TK, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, Levine EG, L..., J Natl Compr Canc Netw, 1/1/2014
• A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma  
  Hussain M, Daignault S, Agarwal N, Grivas PD, Siefker-Radke AO, Puzanov I, MacVicar GR, Levine EG, Srivivas S, Twardowski P, Eisenberger MA, Quinn DI, Vaishampayan UN,..., Cancer, 1/1/2014
• Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: a pilot study  
  Denysschen CA, Burton H, Ademuyiwa F, Levine E, Tetewsky S, O’Connor T, Eur J Cancer Care, 1/1/2014

Books/Book Chapters

• Textbook of Uncommon Cancer 
  Chapter: Sarcomas of the adult prostate gland 
  Levine, EG, Gaeta JF, Huben RF:Editors: Raghavan D, Brecher M, Johnson DH, Meropol NJ, Thigpen JY.John Wiley & Sons, Ltd., Sussex, England1999
• Principles and Practice of Genitourinary Oncology 
  Chapter: Genitourinary sarcomas 
  Levine EG, Brooks JSJ, Spellman J, Velagapudi SEditors: Raghavan D, Scher HI, Leibel SA, Lange PH.J.B. Lippincott Company, Philadelphia, PA1997
• Cancer Patient Follow-up: Surveillance Strategies After Primary Treatment of Cancer 
  Chapter: Breast carcinoma 
  Edge SB, Levine EG, Arredondo MA, Tezcan HEditors: Johnson FE, Virgo KS.Mosby-Year Book, Inc., St. Louis1997

Abstracts/Posters

• Secondary breast cancer following hematologic malignancies
  Tanveer F, Ford LA, Wang ES, Levine EG, O’Connor TL, Wetzler M, Proc Am Soc Clin Oncol, 1/1/2014
• Predictors of complete pathological response (pT0) to neoadjuvant chemotherapy (NAC) in muscle-invasive bladder carcinoma (MIBC)
  Pokuri VK, Syed JR, Yang Z, Field EP, Pili R, Levine EG, Trump DL, Hutson A, Guru K, George S, Proc Am Soc Clin Oncol, 1/1/2014
• Tolerability and cardiac safety of neo/adjuvant trastuzumab-based chemotherapy regimens for HER2+ breast cancer: A single institution experience
  Jitawatanarat P, Kossoff E, Riebandt G, Levine EG, O’Connor TL, Chittawatanarat K, Ngamphaiboon N, Proc Am Soc Clin Oncol, 1/1/2013

Lectures

• The Evaluation System has Changed: Introduction to the Milestones 
  Roswell Park Cancer Institute, Buffalo, NY - 8/12/2014
• Managing Treatments’s Side Effects in Advanced Prostate Cancer 
  Buffalo, NY - 8/24/2012
• Breast Cancer - When to Treat and What to Use? 
  Buffalo, NY - 10/16/2010